These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11122758)

  • 1. Endothelial function as a therapeutic target in coronary artery disease.
    Sharma N; Andrews TC
    Curr Atheroscler Rep; 2000 Jul; 2(4):303-7. PubMed ID: 11122758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary endothelial vasodilator dysfunction: clinical relevance and therapeutic implications.
    Zeiher AM; Schächinger V
    Z Kardiol; 1994; 83 Suppl 4():7-14. PubMed ID: 7856284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial function and cardiovascular prevention: role of blood lipids, exercise, and other risk factors.
    Paterick TE; Fletcher GF
    Cardiol Rev; 2001; 9(5):282-6. PubMed ID: 11520452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical importance of coronary endothelial vasodilator dysfunction and therapeutic options.
    Britten MB; Zeiher AM; Schächinger V
    J Intern Med; 1999 Apr; 245(4):315-27. PubMed ID: 10356593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography and the changing paradigm in coronary artery disease.
    Schelbert HR
    Z Kardiol; 2000; 89 Suppl 4():IV55-60. PubMed ID: 10810777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial dysfunction and coronary risk reduction.
    Charo S; Gokce N; Vita JA
    J Cardiopulm Rehabil; 1998; 18(1):60-7. PubMed ID: 9494884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current trials on angiotensin-converting enzyme inhibitors and endothelial dysfunction.
    Anderson T
    Can J Cardiol; 1998 Jul; 14 Suppl D():33D-34D. PubMed ID: 9713430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial dysfunction and cardiovascular risk factors.
    Grover-Páez F; Zavalza-Gómez AB
    Diabetes Res Clin Pract; 2009 Apr; 84(1):1-10. PubMed ID: 19185380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Endothelial dysfunction and angiotensin-converting enzyme inhibitors in coronary disease].
    Mélon P
    Rev Med Liege; 1998 Jun; 53(6):353-4. PubMed ID: 9713215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of quinapril on coronary blood flow in coronary artery disease patients with endothelial dysfunction. TREND Investigators. Trial on Reversing Endothelial Dysfunction.
    Schlaifer JD; Wargovich TJ; O'Neill B; Mancini GB; Haber HE; Pitt B; Pepine CJ
    Am J Cardiol; 1997 Dec; 80(12):1594-7. PubMed ID: 9416943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherosclerosis-associated endothelial dysfunction.
    Schächinger V; Zeiher AM
    Z Kardiol; 2000; 89 Suppl 9():IX/70-4. PubMed ID: 11151799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ACE inhibition on endothelial dysfunction in patients with chronic heart failure.
    Hornig B; Arakawa N; Drexler H
    Eur Heart J; 1998 Jul; 19 Suppl G():G48-53. PubMed ID: 9717056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibitors, calcium blockers, estrogen and antioxidants in secondary prevention of coronary disease.
    Vogel R
    Can J Cardiol; 1998 Jul; 14 Suppl D():8D-10D. PubMed ID: 9713419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial dysfunction in coronary artery disease.
    Lüscher TF; Tanner FC; Tschudi MR; Noll G
    Annu Rev Med; 1993; 44():395-418. PubMed ID: 8476260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study).
    Anderson TJ; Elstein E; Haber H; Charbonneau F
    J Am Coll Cardiol; 2000 Jan; 35(1):60-6. PubMed ID: 10636260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute effects of ACE inhibition on coronary endothelial dysfunction.
    Nickenig G; Stäblein A; Wassmann S; Wyen C; Müller C; Böhm M
    J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):361-4. PubMed ID: 11967824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study.
    Mancini GB; Henry GC; Macaya C; O'Neill BJ; Pucillo AL; Carere RG; Wargovich TJ; Mudra H; Lüscher TF; Klibaner MI; Haber HE; Uprichard AC; Pepine CJ; Pitt B
    Circulation; 1996 Aug; 94(3):258-65. PubMed ID: 8759064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary endothelial function in health and disease.
    Burnett JC
    Drugs; 1997; 53 Suppl 1():20-9. PubMed ID: 9034752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond lipids - the role of the endothelium in coronary artery disease.
    Aengevaeren WR
    Atherosclerosis; 1999 Sep; 147 Suppl 1():S11-6. PubMed ID: 10575057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of acute coronary syndromes and the potential role of statins.
    Dupuis J
    Atheroscler Suppl; 2001 Feb; 2(1):9-14. PubMed ID: 11286155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.